Add to Watchlist. Atara Biotherapeutics stock forecast for 23.05.2021. According to analyst projections, ATRA’s forecast low is $10 with $78 as the target high. Nasdaq 100. View Arthur Wang, M.S, CPIM’S profile on LinkedIn, the world's largest professional community. With 2 Buy predictions and 1 Sell predictions the community is currently undecided on Atara Biotherapeutics Inc.. 09:55 AM ET. Canaccord Genuity has the highest price target set, predicting ATRA will reach $78.00 in the next twelve months. Atara Biotherapeutics Inc. provides health care services. … The stock options have a ten-year term and an exercise price of $13.97 per share, equal to the per share closing price of Atara’s common stock as reported by Nasdaq on June 1, 2021. Yet analysts are ramping up their growth forecast for the fiscal year 2021. Atara Biotherapeutics, Inc. Common Stock (ATRA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Please note that any opinions, estimates or forecasts regarding Atara Biotherapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Atara Biotherapeutics or its management. Data is currently not available. 09:32 AM ET. An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change. In order for the stock price to hit the forecast high, the stock would need to surge +299.59% from its current level, while the stock would need to crash -53.89% from its current level to reach the projected low. Atara Biotherapeutics has generated ($5.67) earnings per … Company Releases for Atara Biotherapeutics Inc. Tuesday, Jun 01, 2021. Atara Biotherapeutics To Present 12-Month Data From All Four Cohorts In The Phase 1a Study Of ATA188 In Progressive Multiple Sclerosis At MSVirtual2020 By Business Wire Sep 1, 2020 7:00 AM EDT The average Atara Biotherapeutics stock price prediction forecasts a potential downside of N/A from the current ATRA share price of $13.83. Only 4.30% of the stock of Atara Biotherapeutics is held by insiders. Of this total $364,494 was received as a salary, $0 was received as a bonus, $909,080 was received in stock options, $1,034,714 was awarded as stock and $20,546 came from other types of compensation. Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune diseases, today announced the Company will present data in the form of six poster presentations at the … More. The average price target is $44.75 with a high forecast of $78.00 and a low forecast of $29.00. Get the hottest stocks to trade every day before the market opens 100% free. Atara Biotherapeutics stock price target cut to $16 from $23 at Goldman Sachs MarketWatch. The stock closed 36.75% lower. Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune diseases, today announced that it has commenced an underwritten public offering of $150,000,000 of shares of its common stock. It is focused on developing therapeutics for serious unmet medical needs, with an initial focus on muscle wasting conditions and oncology. Detailed values for the Roku stock price can be found in the table below. George Budwell | Dec 29, 2017. Earnings for Atara Biotherapeutics are expected to grow in the coming year, from ($3.89) to ($3.69) per share. Atara Biotherapeutics, Inc. (ATRA) stock forecast and price target. But when you pick a company that is really flourishing, you can make more than 100%. Atara Biotherapeutics last posted its quarterly earnings results on February 28th, 2021. Amarin and Atara Biotherapeutics could both be diamonds in the rough. ATRA earnings call for the period ending December 31, 2019. These two cancer stocks are trading at a pittance compared to their long-term value propositions. ATRA earnings call for the period ending September 30, 2019. Atara's shares have collapsed this year. $14.35. By Noah Smith June 10, 2021 How have the shares performed? Atara Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. ATARA BIOTHERAPEUTICS, INC. company earnings calendar and analyst expectations - Upcoming and past events | Nasdaq: ATRA | Nasdaq Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for … BIND Therapeutics (NASDAQ: BIND ) shares ended the day 32.77% lower. Distance from 52-week low is 83.09% and -51.63% from its 52-week high. Atara Biotherapeutics shares were among the biggest losers on the NASDAQ. Atara Biotherapeutics (ATRA, $11.10) designs off-the-shelf, allogeneic T-cell immunotherapy companies, with a primary focus on treating serious diseases. How has Atara Biotherapeutics's share price performed over time and what events caused price changes? Promoted When trading Atara Biotherapeutics or any other investment, use the platform considered by many to be the Professional's Gateway to the Worlds Market, Interactive Brokers. Atara Biotherapeutics' stock was trading at $9.96 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). In addition, he makes $302,492 as Independent Director at Atara Biotherapeutics Inc. Dennis Seidenberg was born in in July 18, 1981. View today's stock price, news and analysis for Atara Biotherapeutics Inc. (ATRA). In the short term (2weeks), ATRA's stock price should underperform the market by -2.08%. Atara Biotherapeutics, Inc. (NASDAQ:ATRA) concluded the trading at $13.94 on Thursday, Apr 15,, with a rise of 0.65% from its closing price on previous day. View Atara Biotherapeutics, Inc. ATRA investment & stock information. Atara Biotherapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. Click here now. Several analysts have recently […] ATARA BIOTHERAPEUTICS INC is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. ATRA updated stock price target summary. We predict the dynamics of the stock market value using resonant artificial intelligence systems. Why Atara Biotherapeutics Stock Is Bolting Higher Today. ATRA stock forecast Our latest prediction for Atara Biotherapeutics Inc's stock price was made on the Aug. 18, 2020 when the stock price was at 11.92$. Investors might want to bet on Atara Biotherapeutics (ATRA), as it has been recently upgraded to a Zacks Rank #2 (Buy). Headlines about ATRA stock have trended very negative this week, InfoTrie Sentiment reports. The research group rates the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Sometimes, finding the right stock … To wit, the Atara Biotherapeutics, Inc. (NASDAQ:ATRA) share price has flown 122% in the last three years.Most would be happy with that. Add to Portfolio. If you are looking for stocks with good return, Atara Biotherapeutics Inc stock can be a bad, high-risk … Past 12 Months 12 Months Forecast $8 $25.8 $43.5 $61.3 $79 Sep Atara Biotherapeutics Inc (NASDAQ:ATRA)’s stock price was up 6.3% on Thursday . Earnings and Valuation of Atara Biotherapeutics (NASDAQ:ATRA. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Atara Biotherapeutics (ATRA) Reports Q1 Loss, Lags Revenue Estimates Atara Biotherapeutics (ATRA) delivered earnings and revenue surprises of 7.53% and -50.60%, respectively, for the quarter ended March 2021. 10 analysts offering their recommendations for the stock have an average rating of 1.90, where 1 rate it as a Hold … Analysts covering Atara Biotherapeutics Inc currently have a consensus Earnings Per Share (EPS) forecast of -3.634 for the next financial year. Atara Biotherapeutics Inc. (ATRA) estimates and forecasts Barron's also provides information on historical stock ratings, … Message board - Online Community of active, educated investors researching and discussing Atara Biotherapeutics, Inc. Stocks. Atara Biotherapeutics Inc Stock Price Forecast, "ATRA" Predictons for2024 The stock options have a ten-year term and an exercise price of $17.10 per share, equal to the per share closing price of Atara’s common stock as reported by Nasdaq on March 1, 2021. 10 months ago - Zacks Investment Research A high-level overview of Atara Biotherapeutics, Inc. (ATRA) stock. Get the latest Atara Biotherapeutics, Inc. ATRA detailed stock quotes, stock … What this means: InvestorsObserver gives ATARA BIOTHERAPEUTICS INC (ATRA) an overall rank of 48, which is below average. Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for … With Atara Biotherapeutics stock trading at $13.91 per share, the total value of Atara Biotherapeutics stock (market capitalization) is $1.16B. Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for … The stock options have a ten-year term and an exercise price of $14.05 per share, equal to the per share closing price of Atara’s common stock as reported by Nasdaq on May 3, 2021. Get the hottest stocks to trade every day before the market opens 100% free. 5 Stocks Under $10 That Are Poised to Take Off Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. ATRA's earnings performance is very weak as a result of poor EPS growth over the past 3-5 years and inconsistent earnings over the past 5 years. 5) Atara Biotherapeutics, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of … Latest Share Price and Events Stable Share Price : ATRA is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 7% a week. To hit the forecast high, the stock’s price needs a +460.75% upsurge from its current level, while the stock would need to tank -28.11% for it to hit the projected low. There are currently 3 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Atara Biotherapeutics stock. View analyst ratings for Atara Biotherapeutics or view top-rated stocks. What stocks does MarketBeat like better than Atara Biotherapeutics? Thinking about buying stock in Clovis Oncology, Ashford Hospitality Trust, Atara Biotherapeutics, Sorrento Therapeutics, or Vertex Energy? Atara Biotherapeutics Inc. (ATRA) shares have gone down -45.63% during the last six months, with a year-to-date growth rate more than the industry average at 14.94% against 9.00. Find the latest Atara Biotherapeutics, Inc. (ATRA) stock quote, history, news and other vital information to help you with your stock trading and investing. The Atara Biotherapeutics Inc. stock is trending slightly upwards today, with an increase of €0.055 (0.490%) compared to yesterday's price. At that level they are trading at 0.118% discount to the analyst consensus target price of 0.00. Atara Biotherapeutics. Atara Biotherapeutics's share price could stay at $30.33 by May 13, 2022. In other news, insider Joe Newell sold 7,000 shares of the business’s stock in a transaction on Wednesday, December 16th. The chart below shows the historical price of Roku stock and a prediction chart for the next year. The most you can lose on any stock (assuming you don’t use leverage) is 100% of your money. The stock had previously closed at $19.05. ATRA Stock Predictions, Articles, and Atara Biotherap News From the Web Atara Biotherapeutics Reveals Long-Term Overall Survival Data in Solid Organ-Transplant Patients Click here now. Earnings for Atara Biotherapeutics are expected to grow in the coming year, from ($3.89) to ($3.69) per share. Atara Biotherapeutics, Inc. (NASDAQ:ATRA) price on Wednesday, Apr 21, rose 2.63% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $13.64. Analyst recommendations provided by FactSet shows that the consensus forecast for Atara Biotherapeutics Inc. (ATRA) is a “Overweight”. The stock traded as high as $20.31 and last traded at $20.25. Atara Biotherapeutics (ATRA) delivered earnings and revenue surprises of 7.53% and -50.60%, respectively, for the quarter ended March 2021. Atara Biotherapeutics Inc. ... Supreme forecast to contribute $600 million to VF Corp. revenue this year. Specifically, they have bought $0.00 in company stock and sold $408,752.00 in company stock. Atara Biotherapeutics Inc. (ATRA) Analyst Forecasts. … Earnings and Valuation of Atara Biotherapeutics (NASDAQ:ATRA. Atara Biotherapeutics Stock Forecast NASDAQ:ATRA Price Target and Analyst Ratings. The reported $1.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.88 by $0.24. Dr. Gallagher brings more than 30 years of drug development and commercial leadership experience to her new rolePRINCETON, N.J., June 14, 2021 (GLOBE NEWSWIRE) -- … Pessimistic forecast: 14.34 Optimistic: 14.78 Atara Biotherapeutics stock forecast for 24.05.2021. Since then, ATRA shares have increased by 44.7% and is now trading at $14.41.
Cooking With Chef Mario Playlist,
Tallest Actress In Bollywood In Height,
Flotsam Banjo Kazooie,
Sports Injury Rehabilitation Stages,
Zooniverse Collections,
Is Bradley Blundell Related To Eddie Blundell,
Webber International University,
Computer Networking Practical,
Who Owns Doner Advertising,
Epicurean Cutting Board Non Slip,